Results 141 to 150 of about 2,915 (172)

Contingency management to promote treatment engagement in comorbid alcohol use disorder and alcohol‐related liver disease: Findings from a pilot randomized controlled trial

Alcohol, Clinical and Experimental Research, EarlyView.
This pilot trial explored the feasibility of contingency management to promote treatment engagement in patients with comorbid alcohol use disorder and alcohol‐related liver disease. Participants were offered integrated care, and those in the intervention arm were additionally offered a voucher‐based contingency management intervention.
Sofia Hemrage, Nicola Kalk, Naina Shah, Stephen Parkin, Paolo Deluca, Colin Drummond   +5 more
wiley   +1 more source

Beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal clients to involuntary drug and alcohol treatment: A qualitative study

Drug and Alcohol Review, Volume 42, Issue 1, Page 169-180, January 2023., 2023
Abstract Introduction Involuntary drug and alcohol treatment occurs in many countries and its role is often controversial. This can be a particular concern in relation to First Nations or other culturally distinct populations. This study explores beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal Australians to
K. S. Kylie Lee, Lynette M. Bullen, Catherine Zheng, Angela Dawson, Alice Munro, Katherine M. Conigrave   +5 more
wiley   +1 more source

Alcohol and aging: Next‐generation epigenetic clocks predict biological age acceleration in individuals with alcohol use disorder

Alcohol, Clinical and Experimental Research, EarlyView.
Our study investigated the performance of five epigenetic clocks by evaluating associations with alcohol use disorder (AUD) and various alcohol‐related phenotypes. Both DNAm GrimAge versions were associated with AUD and alcohol behaviors/clinical measures in the total sample and age subgroups.
Tyler A. Perlstein, Jeesun Jung, Alexandra C. Wagner, Joshua Reitz, Josephin Wagner, Daniel B. Rosoff, Falk W. Lohoff   +6 more
wiley   +1 more source

Publicly subsidised smoking cessation medicines in times of COVID‐19 in Australia: An interrupted time series analysis

Drug and Alcohol Review, Volume 42, Issue 1, Page 225-232, January 2023., 2023
Abstract Introduction In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID‐19 pandemic that subsequently returned to expected levels. Smoking cessation medicines may not follow this pattern because quit attempts are influenced by a range of factors.
Dolly Baliunas, Coral Gartner, Samantha A. Hollingworth, Clair Sullivan, Tracy Comans, Jason D. Pole   +5 more
wiley   +1 more source

Blood phosphatidylethanol measurements indicate GLP‐1 receptor stimulation causes delayed decreases in alcohol consumption

Alcohol, Clinical and Experimental Research, EarlyView.
Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) are effective for treating obesity (BMI ≥30) and are being investigated as a novel treatment for alcohol use disorder (AUD). This secondary analysis of a randomized clinical trial evaluated the effect of exenatide versus placebo on alcohol consumption using phosphatidylethanol (PEth) in 30 AUD ...
Mathias E. Jensen, Mette K. Klausen, Marianne L. Bergmann, Gitte M. Knudsen, Tina Vilsbøll, Christophe Stove, Anders Fink‐Jensen   +6 more
wiley   +1 more source

Insula under the influence: Alcohol‐induced changes in resting state functional connectivity

Alcohol, Clinical and Experimental Research, EarlyView.
This study explored how acute alcohol consumption alters the resting‐state functional connectivity (rsFC) of the insular cortex (IC) in healthy social drinkers. Alcohol intake disrupted rsFC of the IC with numerous brain regions, including the anterior cingulate cortex, superior temporal gyrus, middle frontal gyrus, precuneus, and basal ganglia ...
Adriana K. Cushnie, Nicholas J. Bush, Landrew S. Sevel, Bethany Stennett‐Blackmon, Allie Farone, Sara Jo Nixon, Michael E. Robinson, Jeff Boissoneault   +7 more
wiley   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Electronic cigarettes and subsequent cigarette smoking in young people: A systematic review

Addiction, EarlyView.
Abstract Aims To assess the evidence for a relationship between the use of e‐cigarettes and subsequent smoking in young people (≤29 years), and whether this differs by demographic characteristics. Methods Systematic review with association direction plots (searches to April 2023).
Rachna Begh, Monserrat Conde, Thomas R. Fanshawe, Dylan Kneale, Lion Shahab, Sufen Zhu, Michael Pesko, Jonathan Livingstone‐Banks, Nicola Lindson, Nancy A. Rigotti, Kate Tudor, Dimitra Kale, Sarah E. Jackson, Karen Rees, Jamie Hartmann‐Boyce   +14 more
wiley   +1 more source

Disentangling the effects of nicotine versus non‐nicotine constituents of tobacco smoke on major depressive disorder: A multivariable Mendelian randomisation study

Addiction, EarlyView.
Abstract Background and aims There is growing evidence that tobacco smoking causes depression, but it is unclear which constituents of tobacco smoke (e.g. nicotine, carbon monoxide) may be responsible. We used Mendelian randomisation (MR) to measure the independent effect of nicotine on depression, by adjusting the effect of circulating nicotine ...
Chloe Burke, Gemma Taylor, Tom P. Freeman, Hannah Sallis, Robyn E. Wootton, Marcus R. Munafò, Christina Dardani, Jasmine Khouja   +7 more
wiley   +1 more source

The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol

Addiction, EarlyView.
Abstract Background and aims Smoking cessation during pregnancy results in short‐ and long‐term health benefits for the mother and infant. Despite public health policies and initiatives to reduce smoking, smoking in pregnancy remains unacceptably high in Australia, particularly among populations of high disadvantage.
Megan L. Hammersley, Gustaaf A. Dekker, Lyle C. Gurrin, Elizabeth A. Hoon, Stefanie Schurer, John W. Lynch, Marnie Aldred, Julia Dalton, Cherise J. Fletcher, Lisa G. Smithers   +9 more
wiley   +1 more source